Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma
Conditions: Advanced Solid Tumors; Gastric Cancer; Esophagogastric Junction Cancer; Pancreatic Cancer Intervention: Drug: IM92 CAR-T cells Sponsor: Beijing Immunochina Medical Science& Technology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2022 Category: Research Source Type: clinical trials